GREY:ICOTF - Post by User
Post by
shareswapperon Apr 09, 2020 1:12pm
403 Views
Post# 30894784
Alexion Knows Bertilimumab Is a Winner
Alexion Knows Bertilimumab Is a WinnerThat's why they snagged the rights from Immune in the first place. There are many potential indications for this drug and Alexion will not want ICO having the Occular aspects. They need to buy ICO out to secure 100% and on top of that they know they will get a winner in Amp B, which is a low cost "no brainer". Watch for M&A here, pretty sure it's in the works.